\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ ongoing\\.\ \(5\)\
\-\ image\\ \\#1\\:\ \(0\)\
\-\ left\\ renal\\ upper\\ polar\\ heterogeneous\\ increased\\ uptake\\,\\ with\\ enlarged\\ area\\ of\\ heterogenous\\ photopenia\\ at\\ the\\ inter\\-\\ to\\ lower\\ pole\\.\\ intense\\ multifocal\\ uptake\\ in\\ the\\ anterior\\ mandible\\ likely\\ represents\\ prior\\ dental\\ work\\ vs\\.\\ periodontal\\ disease\\.\ \(0\)\
\-\ image\\ \\#2\\:\ \(0\)\
\-\ same\\ findings\\,\\ spot\\ view\\.\ \(0\)\
\-\ image\\ \\#3\\ and\\ \\#4\\:\ \(0\)\
\-\ large\\ heterogeneous\\ soft\\ tissue\\ mass\\ infiltrating\\ the\\ left\\ inter\\-\\ and\\ lower\\ renal\\ pole\\ extending\\ to\\ the\\ abdominal\\ wall\\ and\\ invading\\ renal\\ pelvic\\ structures\\ and\\ demonstrating\\ mild\\ heterogeneous\\ contrast\\ enhancement\\.\ \(0\)\
\-\ renal\\ cell\\ carcinoma\ \(60\)\
\-\ renal\\ cell\\ carcinoma\ \(60\)\
\-\ metastasis\\ to\\ the\\ kidney\ \(0\)\
\-\ 54\\ year\\ old\\ female\\ with\\ one\\ month\\ history\\ of\\ left\\ greater\\ than\\ right\\ back\\ pain\\.\ \(1\)\
\-\ tc\\-99m\\ mdp\\ is\\ a\\ commonly\\ employed\\ skeletal\\ radiopharmaceutical\\.\\ diphosphonate\\ labeled\\ tc\\-99m\\ rapidly\\ disperses\\ throughout\\ the\\ extracellular\\ space\\ and\\ accumulates\\ in\\ regions\\ of\\ increased\\ osteogenic\\ \\/\\ osteoblastic\\ activity\\ and\\ regions\\ of\\ increased\\ blood\\ flow\\.\\ adequate\\ bone\\ uptake\\ and\\ target\\ to\\ background\\ ratio\\ for\\ skeletal\\ imaging\\ is\\ generally\\ obtained\\ 2\\-3\\ hours\\ after\\ injection\\.\\ tc\\-99m\\ mdp\\ is\\ primarily\\ renally\\ cleared\\ through\\ glomerular\\ filtration\\.\\ a\\ simple\\ planar\\ gamma\\ scintillation\\ camera\\ windowed\\ around\\ tc\\-99m\\â\\€\\™s\\ characteristic\\ 140\\ kev\\ decay\\ is\\ used\\ to\\ obtain\\ planar\\ whole\\ body\\ and\\ spot\\ views\\.\\ spect\\ can\\ be\\ added\\ if\\ further\\ lesion\\ localization\\ is\\ required\\.\\ \ \(0\)\
\-\ in\\ a\\ normal\\ whole\\ body\\ bone\\ scan\\,\\ activity\\ is\\ greatest\\ in\\ the\\ axial\\ skeleton\\ and\\ relatively\\ lower\\ in\\ the\\ appendicular\\ skeleton\\.\\ the\\ kidneys\\ should\\ always\\ be\\ visualized\\ and\\ be\\ less\\ intense\\ than\\ the\\ lumbar\\ spine\\.\\ \ \(0\)\
\-\ asymmetry\\ or\\ irregularity\\ of\\ the\\ kidneys\\ should\\ always\\ spur\\ further\\ evaluation\\.\\ frequently\\ ultrasound\\ or\\ ct\\ are\\ chosen\\ based\\ on\\ the\\ clinical\\ circumstances\\,\\ risk\\ factors\\,\\ and\\ suspicions\\.\\ in\\ this\\ case\\ the\\ patient\\ received\\ a\\ contrast\\ enhanced\\ ct\\ of\\ the\\ abdomen\\ and\\ pelvis\\.\\ \ \(0\)\
\-\ renal\\ cell\\ carcinoma\\ \\(rcc\\)\\ presents\\ most\\ commonly\\ with\\ hematuria\\,\\ flank\\ pain\\,\\ palpable\\ mass\\,\\ and\\ weight\\ loss\\.\\ risk\\ factors\\ include\\ tobacco\\ use\\,\\ family\\ history\\,\\ and\\ chronic\\ dialysis\\ among\\ others\\.\\ on\\ ct\\,\\ heterogeneous\\ contrast\\ enhancement\\ and\\ varying\\ degrees\\ of\\ hemorrhage\\ and\\ necrosis\\ are\\ apparent\\.\\ ten\\ percent\\ calcify\\ and\\ a\\ few\\ percent\\ demonstrate\\ cystic\\ regions\\.\\ on\\ ultrasound\\,\\ rcc\\ is\\ most\\ frequently\\ hyperechoic\\ but\\ can\\ be\\ hypoechoic\\ up\\ to\\ 30\\%\\ of\\ the\\ time\\.\\ stage\\ i\\ disease\\ is\\ confined\\ to\\ the\\ kidney\\,\\ stage\\ ii\\ is\\ confined\\ to\\ gerota\\â\\€\\™s\\ fascia\\,\\ stage\\ iii\\ demonstrates\\ venous\\ invasion\\ \\(a\\)\\ or\\ lymph\\ node\\ metastasis\\ \\(b\\)\\ or\\ both\\ \\(c\\)\\,\\ and\\ stage\\ iv\\ demonstrates\\ direct\\ extension\\ into\\ adjacent\\ organs\\ and\\/or\\ distant\\ organ\\ metastasis\\.\\ \ \(0\)\
\-\ treatment\\ may\\ include\\ radical\\ nephrectomy\\,\\ chemotherapy\\,\\ or\\ radiotherapy\\ \\(for\\ palliation\\)\\.\\ at\\ the\\ time\\ of\\ this\\ evaluation\\,\\ this\\ patient\\ was\\ still\\ undergoing\\ evaluation\\ for\\ treatment\\.\\ however\\ based\\ on\\ the\\ images\\ provided\\,\\ there\\ is\\ extrarenal\\ involvement\\ without\\ venous\\ invasion\\ or\\ nodal\\ metastasis\\ placing\\ this\\ patient\\â\\€\\™s\\ disease\\ at\\ least\\ at\\ stage\\ ii\\ \\(50\\%\\ 5\\-year\\ survival\\)\\.\\ \\ \ \(0\)\
\-\ this\\ is\\ a\\ good\\ example\\ of\\ how\\ a\\ nuclear\\ medicine\\ tc\\-99m\\ bone\\ scan\\ used\\ in\\ search\\ of\\ spinal\\ disease\\ can\\ stimulate\\ the\\ discovery\\ of\\ a\\ primary\\ malignancy\\ \\(likely\\ accounting\\ for\\ this\\ patient\\â\\€\\™s\\ symptoms\\)\\ and\\ prompt\\ appropriate\\ treatment\\.\\ any\\ renal\\ asymmetry\\,\\ whether\\ in\\ size\\,\\ shape\\ or\\ degree\\ of\\ uptake\\ on\\ tc\\-99m\\ bone\\ scan\\ must\\ not\\ be\\ overlooked\\ and\\ should\\ always\\ prompt\\ further\\ clinical\\ and\\/or\\ imaging\\ evaluation\\.\\ \ \(0\)\
\-\ while\\ renal\\ assymetry\\ on\\ tc\\-99m\\ bone\\ scan\\ can\\ prompt\\ the\\ discovery\\ of\\ primary\\ renal\\ cell\\ carcinoma\\,\\ it\\ is\\ not\\ a\\ suggested\\ means\\ of\\ evaluating\\ for\\ renal\\ cell\\ metastasis\\.\\ bone\\ scan\\ evaluation\\ for\\ metastasis\\ is\\ ideal\\ for\\ osteoblastic\\ rather\\ than\\ osteolytic\\ \\(rcc\\)\\ lesions\\.\\ while\\ some\\ osteolytic\\ lesions\\ are\\ noted\\ on\\ bone\\ scan\\,\\ sensitivity\\ is\\ in\\ the\\ neighborhood\\ of\\ 50\\%\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ thrall\\ jh\\,\\ ziessman\\ ha\\.\\ nuclear\\ medicine\\,\\ the\\ requisites\\,\\ 2nd\\ edition\\.\\ mosby\\ 2001\\.\ \(0\)\
\-\ weissleder\\ r\\,\\ wittenberg\\ j\\,\\ harisinghani\\ mg\\.\\ primer\\ of\\ diagnostic\\ imaing\\,\\ 3rd\\ edition\\.\\ mosby\\ 2003\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tc\\-99m\\:\\ 0\\.049906349691525846\ \(0\)\
\-\ renal\\:\\ 0\\.03748139488259955\ \(0\)\
\-\ metastasis\\:\\ 0\\.02801822475591177\ \(0\)\
\-\ stage\\:\\ 0\\.02660609072210472\ \(0\)\
\-\ inter\\-\\:\\ 0\\.025738739923989774\ \(0\)\
\-\ rcc\\:\\ 0\\.025274434976247047\ \(0\)\
\-\ prompt\\:\\ 0\\.02303724246340329\ \(0\)\
\-\ bone\\:\\ 0\\.021699332511268744\ \(0\)\
\-\ scan\\:\\ 0\\.02095420257313558\ \(0\)\
\-\ uptake\\:\\ 0\\.019824720728141385\ \(0\)\
\-\ \\#\\:\\ 0\\.019571892665348253\ \(0\)\
\-\ always\\:\\ 0\\.019255523282495916\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.01834858485719711\ \(0\)\
\-\ evaluation\\:\\ 0\\.018118531356400056\ \(0\)\
\-\ discovery\\:\\ 0\\.01764359037000501\ \(0\)\
\-\ mdp\\:\\ 0\\.017141837795036665\ \(0\)\
\-\ regions\\:\\ 0\\.017125154651947746\ \(0\)\
\-\ osteolytic\\:\\ 0\\.01684962331749803\ \(0\)\
\-\ cell\\:\\ 0\\.016848472347310118\ \(0\)\
\-\ planar\\:\\ 0\\.01622604930202924\ \(0\)\
\-\ osteoblastic\\:\\ 0\\.016009675660704506\ \(0\)\
\-\ asymmetry\\:\\ 0\\.01561980298150882\ \(0\)\
\-\ skeleton\\:\\ 0\\.015275910906599674\ \(0\)\
\-\ confined\\:\\ 0\\.015042209570326575\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.014914024757053756\ \(0\)\
\-\ edition\\:\\ 0\\.014896193743831212\ \(0\)\
\-\ whole\\:\\ 0\\.014690011065834268\ \(0\)\
\-\ mosby\\:\\ 0\\.014690011065834268\ \(0\)\
\-\ s\\:\\ 0\\.014311052070742113\ \(0\)\
\-\ carcinoma\\:\\ 0\\.014142643328559804\ \(0\)\
\-\ percent\\:\\ 0\\.01359601559301263\ \(0\)\
\-\ spot\\:\\ 0\\.01341900939792815\ \(0\)\
\-\ intense\\:\\ 0\\.0132118510447244\ \(0\)\
\-\ nuclear\\:\\ 0\\.012872406355335021\ \(0\)\
\-\ disperses\\:\\ 0\\.012869369961994887\ \(0\)\
\-\ renally\\:\\ 0\\.012869369961994887\ \(0\)\
\-\ windowed\\:\\ 0\\.012869369961994887\ \(0\)\
\-\ neighborhood\\:\\ 0\\.012869369961994887\ \(0\)\
\-\ skeletal\\:\\ 0\\.012322331602428929\ \(0\)\
\-\ invasion\\:\\ 0\\.012014709658902428\ \(0\)\
\-\ should\\:\\ 0\\.011930840329440001\ \(0\)\
\-\ further\\:\\ 0\\.011901215219563175\ \(0\)\
\-\ accumulates\\:\\ 0\\.011857476267746792\ \(0\)\
\-\ wittenberg\\:\\ 0\\.011857476267746792\ \(0\)\
\-\ medicine\\:\\ 0\\.011834582450127713\ \(0\)\
\-\ image\\:\\ 0\\.01168987956042745\ \(0\)\
\-\ pole\\:\\ 0\\.011618208808802979\ \(0\)\
\-\ is\\:\\ 0\\.011492074302753516\ \(0\)\
\-\ kidneys\\:\\ 0\\.011482383945635407\ \(0\)\
\-\ \\,\\:\\ 0\\.011460718102191729\ \(0\)\
\-\ can\\:\\ 0\\.011318086729746392\ \(0\)\
\-\ filtration\\:\\ 0\\.011265556401895457\ \(0\)\
\-\ decay\\:\\ 0\\.011265556401895457\ \(0\)\
\-\ suspicions\\:\\ 0\\.011265556401895457\ \(0\)\
\-\ harisinghani\\:\\ 0\\.011265556401895457\ \(0\)\
\-\ factors\\:\\ 0\\.01120813045706839\ \(0\)\
\-\ glomerular\\:\\ 0\\.010845582573498696\ \(0\)\
\-\ kev\\:\\ 0\\.010845582573498696\ \(0\)\
\-\ ideal\\:\\ 0\\.010845582573498696\ \(0\)\
\-\ frequently\\:\\ 0\\.010813228133167752\ \(0\)\
\-\ ii\\:\\ 0\\.010760933457061094\ \(0\)\
\-\ and\\/or\\:\\ 0\\.010544559815736357\ \(0\)\
\-\ periodontal\\:\\ 0\\.010519825564280872\ \(0\)\
\-\ scintillation\\:\\ 0\\.010519825564280872\ \(0\)\
\-\ assymetry\\:\\ 0\\.010519825564280872\ \(0\)\
\-\ weissleder\\:\\ 0\\.010519825564280872\ \(0\)\
\-\ imaing\\:\\ 0\\.010519825564280872\ \(0\)\
\-\ primer\\:\\ 0\\.010253662707647361\ \(0\)\
\-\ or\\:\\ 0\\.010234539040505041\ \(0\)\
\-\ polar\\:\\ 0\\.010028625218848444\ \(0\)\
\-\ photopenia\\:\\ 0\\.010028625218848444\ \(0\)\
\-\ extracellular\\:\\ 0\\.010028625218848444\ \(0\)\
\-\ extrarenal\\:\\ 0\\.010028625218848444\ \(0\)\
\-\ spur\\:\\ 0\\.009833688879250601\ \(0\)\
\-\ palliation\\:\\ 0\\.009833688879250601\ \(0\)\
\-\ ziessman\\:\\ 0\\.009833688879250601\ \(0\)\
\-\ than\\:\\ 0\\.00980605337920412\ \(0\)\
\-\ circumstances\\:\\ 0\\.009661742841796026\ \(0\)\
\-\ gerota\\:\\ 0\\.009661742841796026\ \(0\)\
\-\ stimulate\\:\\ 0\\.009661742841796026\ \(0\)\
\-\ thrall\\:\\ 0\\.009661742841796026\ \(0\)\
\-\ be\\:\\ 0\\.009618662214189264\ \(0\)\
\-\ used\\:\\ 0\\.009571340604227626\ \(0\)\
\-\ based\\:\\ 0\\.009514424415377986\ \(0\)\
\-\ diphosphonate\\:\\ 0\\.009507931870032777\ \(0\)\
\-\ camera\\:\\ 0\\.009507931870032777\ \(0\)\
\-\ overlooked\\:\\ 0\\.009507931870032777\ \(0\)\
\-\ 50\\:\\ 0\\.009491965012098699\ \(0\)\
\-\ commonly\\:\\ 0\\.009414690345855887\ \(0\)\
\-\ activity\\:\\ 0\\.00936072008403369\ \(0\)\
\-\ 2001\\.\\:\\ 0\\.009241769013399266\ \(0\)\
\-\ increased\\:\\ 0\\.009155407803502142\ \(0\)\
\-\ cleared\\:\\ 0\\.009124918345262717\ \(0\)\
\-\ chosen\\:\\ 0\\.009124918345262717\ \(0\)\
\-\ 5\\-year\\:\\ 0\\.009124918345262717\ \(0\)\
\-\ venous\\:\\ 0\\.00905630837505731\ \(0\)\
\-\ risk\\:\\ 0\\.0090370997003185\ \(0\)\
\-\ osteogenic\\:\\ 0\\.00901673152460035\ \(0\)\
\-\ placing\\:\\ 0\\.00901673152460035\ \(0\)\
\-\ jh\\:\\ 0\\.00901673152460035\ \(0\)\
\-\ 140\\:\\ 0\\.008821795185002505\ \(0\)\
\-\ added\\:\\ 0\\.008821795185002505\ \(0\)\
\-\ kidney\\:\\ 0\\.008789440744671561\ \(0\)\
\-\ radiopharmaceutical\\:\\ 0\\.008733292087460265\ \(0\)\
\-\ \\%\\:\\ 0\\.00872987313874164\ \(0\)\
\-\ labeled\\:\\ 0\\.008649849147547932\ \(0\)\
\-\ ten\\:\\ 0\\.008649849147547932\ \(0\)\
\-\ calcify\\:\\ 0\\.008649849147547932\ \(0\)\
\-\ employed\\:\\ 0\\.008570918897518333\ \(0\)\
\-\ accounting\\:\\ 0\\.008496038175784681\ \(0\)\
\-\ \\(\\:\\ 0\\.008436341328395451\ \(0\)\
\-\ appendicular\\:\\ 0\\.008424811658749014\ \(0\)\
\-\ this\\:\\ 0\\.008418720116620143\ \(0\)\
\-\ lower\\:\\ 0\\.00841691417239648\ \(0\)\
\-\ contrast\\:\\ 0\\.008377119796239002\ \(0\)\
\-\ nodal\\:\\ 0\\.008356899227165229\ \(0\)\
\-\ \\)\\:\\ 0\\.008333286915191883\ \(0\)\
\-\ invading\\:\\ 0\\.008292006143120216\ \(0\)\
\-\ spect\\:\\ 0\\.008292006143120216\ \(0\)\
\-\ fascia\\:\\ 0\\.008292006143120216\ \(0\)\
\-\ ha\\:\\ 0\\.008292006143120216\ \(0\)\
\-\ background\\:\\ 0\\.008170281166566857\ \(0\)\
\-\ disease\\:\\ 0\\.008156131627536959\ \(0\)\
\-\ localization\\:\\ 0\\.00811302465101462\ \(0\)\
\-\ search\\:\\ 0\\.00811302465101462\ \(0\)\
\-\ body\\:\\ 0\\.008102959745077618\ \(0\)\
\-\ requisites\\:\\ 0\\.008057929281696597\ \(0\)\
\-\ obtain\\:\\ 0\\.007904118309933346\ \(0\)\
\-\ means\\:\\ 0\\.007904118309933346\ \(0\)\
\-\ ongoing\\:\\ 0\\.00785624995544723\ \(0\)\
\-\ while\\:\\ 0\\.007850070773291426\ \(0\)\
\-\ dental\\:\\ 0\\.00780990149075441\ \(0\)\
\-\ dialysis\\:\\ 0\\.00780990149075441\ \(0\)\
\-\ radical\\:\\ 0\\.00780990149075441\ \(0\)\
\-\ clinical\\:\\ 0\\.007676816934499282\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.007597956950835435\ \(0\)\
\-\ treatment\\:\\ 0\\.007574964786573228\ \(0\)\
\-\ gamma\\:\\ 0\\.007559025203270237\ \(0\)\
\-\ target\\:\\ 0\\.0075211047851632875\ \(0\)\
\-\ tobacco\\:\\ 0\\.0075211047851632875\ \(0\)\
\-\ for\\:\\ 0\\.007450740205108037\ \(0\)\
\-\ among\\:\\ 0\\.007412917964500918\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0074018177664417605\ \(0\)\
\-\ on\\:\\ 0\\.0073974264037343015\ \(0\)\
\-\ primary\\:\\ 0\\.007390902957359697\ \(0\)\
\-\ mandible\\:\\ 0\\.007378566873391146\ \(0\)\
\-\ how\\:\\ 0\\.007378566873391146\ \(0\)\
\-\ others\\:\\ 0\\.007345005532917134\ \(0\)\
\-\ varying\\:\\ 0\\.007312198444082012\ \(0\)\
\-\ organ\\:\\ 0\\.007312198444082012\ \(0\)\
\-\ distant\\:\\ 0\\.007280112448872121\ \(0\)\
\-\ organs\\:\\ 0\\.007158387472318762\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.007073323372867703\ \(0\)\
\-\ time\\:\\ 0\\.007047010882450547\ \(0\)\
\-\ sensitivity\\:\\ 0\\.007046035587448501\ \(0\)\
\-\ likely\\:\\ 0\\.007037342966235493\ \(0\)\
\-\ include\\:\\ 0\\.006998988286219815\ \(0\)\
\-\ evaluating\\:\\ 0\\.006941715932000115\ \(0\)\
\-\ rapidly\\:\\ 0\\.006916760554833253\ \(0\)\
\-\ ratio\\:\\ 0\\.006916760554833253\ \(0\)\
\-\ greatest\\:\\ 0\\.006892224615685252\ \(0\)\
\-\ example\\:\\ 0\\.006868094247873265\ \(0\)\
\-\ mg\\:\\ 0\\.006844356261199134\ \(0\)\
\-\ infiltrating\\:\\ 0\\.006775373947548701\ \(0\)\
\-\ at\\:\\ 0\\.00676066074646209\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.0067311325614241345\ \(0\)\
\-\ multifocal\\:\\ 0\\.006709504698964075\ \(0\)\
\-\ whether\\:\\ 0\\.006709504698964075\ \(0\)\
\-\ adequate\\:\\ 0\\.006688192583020786\ \(0\)\
\-\ survival\\:\\ 0\\.006688192583020786\ \(0\)\
\-\ enhancement\\:\\ 0\\.006687558441235141\ \(0\)\
\-\ lesions\\:\\ 0\\.006679008777646562\ \(0\)\
\-\ irregularity\\:\\ 0\\.006667187126886334\ \(0\)\
\-\ \\:\\:\\ 0\\.006600144910894394\ \(0\)\
\-\ 54\\:\\ 0\\.0065860632565873396\ \(0\)\
\-\ primarily\\:\\ 0\\.006547131509022142\ \(0\)\
\-\ shape\\:\\ 0\\.006490613972991936\ \(0\)\
\-\ heterogenous\\:\\ 0\\.006401024270252823\ \(0\)\
\-\ suggested\\:\\ 0\\.0063497960661487805\ \(0\)\
\-\ degrees\\:\\ 0\\.0063331118386690385\ \(0\)\
\-\ 2003\\:\\ 0\\.0062682187546240255\ \(0\)\
\-\ least\\:\\ 0\\.006252436395347798\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.0062368228345934225\ \(0\)\
\-\ 2nd\\:\\ 0\\.006221374499804317\ \(0\)\
\-\ 3rd\\:\\ 0\\.006175986781453906\ \(0\)\
\-\ \\/\\:\\ 0\\.006161165801214464\ \(0\)\
\-\ simple\\:\\ 0\\.006146493778070666\ \(0\)\
\-\ undergoing\\:\\ 0\\.006117584833112739\ \(0\)\
\-\ represents\\:\\ 0\\.0059941433907360064\ \(0\)\
\-\ still\\:\\ 0\\.005942461745406202\ \(0\)\
\-\ c\\:\\ 0\\.00592982223775202\ \(0\)\
\-\ rather\\:\\ 0\\.00592982223775202\ \(0\)\
\-\ hematuria\\:\\ 0\\.005917291225063856\ \(0\)\
\-\ direct\\:\\ 0\\.005892547344313823\ \(0\)\
\-\ b\\:\\ 0\\.005880330921437156\ \(0\)\
\-\ appropriate\\:\\ 0\\.005880330921437156\ \(0\)\
\-\ flank\\:\\ 0\\.005868215880831761\ \(0\)\
\-\ iii\\:\\ 0\\.00585620055362517\ \(0\)\
\-\ imaging\\:\\ 0\\.0058454710203083285\ \(0\)\
\-\ work\\:\\ 0\\.005844283311816176\ \(0\)\
\-\ degree\\:\\ 0\\.005844283311816176\ \(0\)\
\-\ injection\\:\\ 0\\.0058207367688528425\ \(0\)\
\-\ received\\:\\ 0\\.005797563996361907\ \(0\)\
\-\ a\\:\\ 0\\.005789778128738704\ \(0\)\
\-\ most\\:\\ 0\\.005760102603585623\ \(0\)\
\-\ node\\:\\ 0\\.005708384883982582\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.005686916055676457\ \(0\)\
\-\ must\\:\\ 0\\.005686916055676457\ \(0\)\
\-\ r\\:\\ 0\\.005665758380782199\ \(0\)\
\-\ j\\:\\ 0\\.005634585936299616\ \(0\)\
\-\ generally\\:\\ 0\\.005614168064803646\ \(0\)\
\-\ few\\:\\ 0\\.005614168064803646\ \(0\)\
\-\ in\\:\\ 0\\.005536605943448605\ \(0\)\
\-\ apparent\\:\\ 0\\.0055161544840187865\ \(0\)\
\-\ demonstrates\\:\\ 0\\.005449988909936309\ \(0\)\
\-\ demonstrating\\:\\ 0\\.005415434963599879\ \(0\)\
\-\ provided\\:\\ 0\\.005380466728530547\ \(0\)\
\-\ relatively\\:\\ 0\\.005337902371900685\ \(0\)\
\-\ enhanced\\:\\ 0\\.005337902371900685\ \(0\)\
\-\ good\\:\\ 0\\.005337902371900685\ \(0\)\
\-\ lumbar\\:\\ 0\\.0053047224433203114\ \(0\)\
\-\ characteristic\\:\\ 0\\.00528032320102288\ \(0\)\
\-\ and\\:\\ 0\\.0052557373936414145\ \(0\)\
\-\ ct\\:\\ 0\\.005234906511206028\ \(0\)\
\-\ around\\:\\ 0\\.0051941942364068855\ \(0\)\
\-\ references\\:\\ 0\\.005186610562133741\ \(0\)\
\-\ i\\:\\ 0\\.005156663788654758\ \(0\)\
\-\ same\\:\\ 0\\.005141917663127016\ \(0\)\
\-\ views\\:\\ 0\\.005141917663127016\ \(0\)\
\-\ pelvic\\:\\ 0\\.00512007405337999\ \(0\)\
\-\ family\\:\\ 0\\.005112864883101767\ \(0\)\
\-\ are\\:\\ 0\\.005101637397939862\ \(0\)\
\-\ visualized\\:\\ 0\\.005049535984371511\ \(0\)\
\-\ lymph\\:\\ 0\\.005035828334225762\ \(0\)\
\-\ patient\\:\\ 0\\.005001996676884017\ \(0\)\
\-\ to\\:\\ 0\\.004987656740939986\ \(0\)\
\-\ diagnostic\\:\\ 0\\.004943317948922711\ \(0\)\
\-\ use\\:\\ 0\\.004930568051158106\ \(0\)\
\-\ necrosis\\:\\ 0\\.004924234618167452\ \(0\)\
\-\ vs\\:\\ 0\\.004911649591825982\ \(0\)\
\-\ hours\\:\\ 0\\.004905397530815761\ \(0\)\
\-\ malignancy\\:\\ 0\\.004820568872702943\ \(0\)\
\-\ structures\\:\\ 0\\.00480301530632805\ \(0\)\
\-\ 30\\:\\ 0\\.004797210710153394\ \(0\)\
\-\ greater\\:\\ 0\\.004685717310467885\ \(0\)\
\-\ view\\:\\ 0\\.004680360042016845\ \(0\)\
\-\ throughout\\:\\ 0\\.0046697041259852945\ \(0\)\
\-\ involvement\\:\\ 0\\.004572173221354476\ \(0\)\
\-\ iv\\:\\ 0\\.0045524451641767785\ \(0\)\
\-\ pelvis\\:\\ 0\\.004532980155608217\ \(0\)\
\-\ n\\/a\\:\\ 0\\.00451854985015925\ \(0\)\
\-\ required\\:\\ 0\\.0044901102361857865\ \(0\)\
\-\ weight\\:\\ 0\\.004471453700935569\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.004471453700935569\ \(0\)\
\-\ spinal\\:\\ 0\\.004466826584495745\ \(0\)\
\-\ extension\\:\\ 0\\.004453032585666647\ \(0\)\
\-\ the\\:\\ 0\\.0044401230123792225\ \(0\)\
\-\ obtained\\:\\ 0\\.0044348410229837106\ \(0\)\
\-\ palpable\\:\\ 0\\.0044213445877369206\ \(0\)\
\-\ enlarged\\:\\ 0\\.004256381124648184\ \(0\)\
\-\ less\\:\\ 0\\.004224729933317784\ \(0\)\
\-\ extending\\:\\ 0\\.004193750436262477\ \(0\)\
\-\ left\\:\\ 0\\.004187322347180649\ \(0\)\
\-\ size\\:\\ 0\\.00418230054215879\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.004152199392957716\ \(0\)\
\-\ space\\:\\ 0\\.004126360594272459\ \(0\)\
\-\ flow\\:\\ 0\\.004122706389574476\ \(0\)\
\-\ back\\:\\ 0\\.004115425307076609\ \(0\)\
\-\ spine\\:\\ 0\\.004108180359131895\ \(0\)\
\-\ area\\:\\ 0\\.003944286487787251\ \(0\)\
\-\ adjacent\\:\\ 0\\.003944286487787251\ \(0\)\
\-\ any\\:\\ 0\\.003928226325652983\ \(0\)\
\-\ some\\:\\ 0\\.003788216429002568\ \(0\)\
\-\ month\\:\\ 0\\.0037425029792709625\ \(0\)\
\-\ abdomen\\:\\ 0\\.0036954514786798486\ \(0\)\
\-\ loss\\:\\ 0\\.0036211155802458967\ \(0\)\
\-\ wall\\:\\ 0\\.003613370978450724\ \(0\)\
\-\ not\\:\\ 0\\.0036053099904874023\ \(0\)\
\-\ cystic\\:\\ 0\\.0035980039521923478\ \(0\)\
\-\ axial\\:\\ 0\\.0035602795271063815\ \(0\)\
\-\ through\\:\\ 0\\.003543002946599808\ \(0\)\
\-\ chronic\\:\\ 0\\.0035138534786963503\ \(0\)\
\-\ 4\\:\\ 0\\.0034758713944219636\ \(0\)\
\-\ however\\:\\ 0\\.0034735300081709056\ \(0\)\
\-\ mass\\:\\ 0\\.003469959144372451\ \(0\)\
\-\ history\\:\\ 0\\.0034458818619184915\ \(0\)\
\-\ blood\\:\\ 0\\.003404979667896787\ \(0\)\
\-\ if\\:\\ 0\\.0033850269106286647\ \(0\)\
\-\ one\\:\\ 0\\.0033806297566578744\ \(0\)\
\-\ up\\:\\ 0\\.003354521388400326\ \(0\)\
\-\ mild\\:\\ 0\\.0032850415385856013\ \(0\)\
\-\ anterior\\:\\ 0\\.0032128362390696896\ \(0\)\
\-\ prior\\:\\ 0\\.003203084338981552\ \(0\)\
\-\ both\\:\\ 0\\.003185693417060031\ \(0\)\
\-\ abdominal\\:\\ 0\\.003118130274630825\ \(0\)\
\-\ symptoms\\:\\ 0\\.003108989017369546\ \(0\)\
\-\ pain\\:\\ 0\\.0030470311460751376\ \(0\)\
\-\ soft\\:\\ 0\\.0030378492905015326\ \(0\)\
\-\ upper\\:\\ 0\\.00301033650418791\ \(0\)\
\-\ 1\\:\\ 0\\.0029683596612550462\ \(0\)\
\-\ into\\:\\ 0\\.0029683596612550462\ \(0\)\
\-\ tissue\\:\\ 0\\.002956819253215465\ \(0\)\
\-\ noted\\:\\ 0\\.002956819253215465\ \(0\)\
\-\ without\\:\\ 0\\.0029372454983330803\ \(0\)\
\-\ 3\\:\\ 0\\.00292113215577597\ \(0\)\
\-\ of\\:\\ 0\\.002891335202285844\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0028707330530409352\ \(0\)\
\-\ it\\:\\ 0\\.0028041582255956448\ \(0\)\
\-\ may\\:\\ 0\\.0027362457940118593\ \(0\)\
\-\ case\\:\\ 0\\.002729203551631052\ \(0\)\
\-\ large\\:\\ 0\\.0027277991705563207\ \(0\)\
\-\ 2\\:\\ 0\\.002686283936511746\ \(0\)\
\-\ but\\:\\ 0\\.0026605887606329015\ \(0\)\
\-\ findings\\:\\ 0\\.0026552364026130796\ \(0\)\
\-\ after\\:\\ 0\\.002581023653444091\ \(0\)\
\-\ female\\:\\ 0\\.002564613534960341\ \(0\)\
\-\ presents\\:\\ 0\\.0025483858328582856\ \(0\)\
\-\ lesion\\:\\ 0\\.002540956534307233\ \(0\)\
\-\ images\\:\\ 0\\.0023930859736486917\ \(0\)\
\-\ normal\\:\\ 0\\.001955638619852702\ \(0\)\
\-\ \\.\\:\\ 0\\.0019174931906595799\ \(0\)\
\-\ there\\:\\ 0\\.00185651906053283\ \(0\)\
\-\ was\\:\\ 0\\.0014427409083411485\ \(0\)\
\-\ year\\:\\ 0\\.0013957741157268827\ \(0\)\
\-\ right\\:\\ 0\\.001316250670234185\ \(0\)\
\-\ old\\:\\ 0\\.0012772767837405175\ \(0\)\
\-\ with\\:\\ 0\\.0005124270485688602\ \(0\)\
